The Huddersfield Royal Infirmary is a hospital situated in the English town of Huddersfield, part of Calderdale and Huddersfield NHS Foundation Trust. It is situated in the suburb of Lindley and provides general services, emergency services and some specialist services.

There are 810 beds in Huddersfield Royal Infirmary.

During the past decade, Huddersfield Royal Infirmary conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 5 clinical trials were completed, i.e. on average, 38.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Huddersfield Royal Infirmary" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Medical Research Council" with 5 trials sponsored, "Institute of Cancer Research, United Kingdom" with 4 trials sponsored, "University of Leeds" with 4 trials sponsored and "University Hospital Southampton NHS Foundation Trust" with 4 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Huddersfield Royal Infirmary" #1 collaborator was "Cancer Research UK" with 8 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials as a collaborator, "NHS Greater Glasgow and Clyde" with 2 trials as a collaborator and "Roche Pharma AG" with 2 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "Huddersfield Royal Infirmary" are "Breast Cancer" (13 trials), "Colorectal Cancer" (3 trials), "Lymphoma" (3 trials), "Metastatic Cancer" (3 trials) and "Bladder Cancer" (2 trials). Many other conditions were trialed in "Huddersfield Royal Infirmary" in a lesser frequency.

Most popular intervention types in "Huddersfield Royal Infirmary" are "Drug" (45 trials), "Procedure" (13 trials), "Biological" (8 trials), "Other" (6 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "capecitabine" (7 trials), "cyclophosphamide" (7 trials), "fluorouracil" (6 trials), "adjuvant therapy" (5 trials) and "carboplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Huddersfield Royal Infirmary" are 38 trials for "All" genders, 9 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Huddersfield Royal Infirmary". undefined are not yet recruiting, 7 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Huddersfield Royal Infirmary, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Huddersfield Royal Infirmary, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".